Venmax Drugs And Pharmaceuticals Ltd.

VENMAX

₹24.24

4.98% (1.15)

Market Cap

₹12 Cr.

P/E

0.00

Venmax Drugs And Pharmaceuticals Ltd.
Overview
Financials
Benchmarking
Shareholding

About

Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs intermediates primarily in India. It primarily offers trityl chloride. The company, formerly known as Yenkey … Read more

Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs int… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Other Income

Other income component is making ratios of the company look optically better
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
ROE

Financial leverage has increased roe over 10 years
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Current vs Historic Valuation

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Venmax Drugs And Pharmaceuticals Ltd. Business

What does Venmax Drugs&Pharma do?

Who are the competitors of Venmax Drugs&Pharma?

Venmax Drugs&Pharma major competitors are Unjha Formulations, Decipher Labs, Cian Healthcare, Beryl Drugs, Parmax Pharma, Hind Bio Science, iStreet Network.
Market Cap of Venmax Drugs&Pharma is ₹12 Crs.
While the median market cap of its peers are ₹10 Crs.

Is Venmax Drugs&Pharma financially stable compared to its competitors?

Venmax Drugs&Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Venmax Drugs&Pharma is -116.57 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Venmax Drugs And Pharmaceuticals Ltd.

Venmax Drugs And Pharmaceuticals Ltd.

About

Timeline

Company Timeline

6 Yes

2 Neutral

7 No

2 No Data

Accounting & Shareholding

Pledge

Revenue Recognition

Depreciation Effect

Promoter Holding

Retail Holding

Other Income

Contingent Liabilities

Price & Performance

Capex vs ROCE

Working Capital

Debt

ROE

Share price

Sales Growth

Margin Stability

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Product Wise Break-Up

UNLOCK PREMIUM

What does Venmax Drugs&Pharma do?

Who are the competitors of Venmax Drugs&Pharma?

Is Venmax Drugs&Pharma financially stable compared to its competitors?

SIGN UP FOR FREE